The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume -, Issue -, Pages 1-17
Publisher
Informa UK Limited
Online
2019-03-20
DOI
10.1080/14760584.2019.1588727
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models
- (2018) M. Domenech de Cellès et al. Human Vaccines & Immunotherapeutics
- Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims
- (2017) P. O. BUCK et al. EPIDEMIOLOGY AND INFECTION
- Interleukin-7 and Immunosenescence
- (2017) Vanloan Nguyen et al. Journal of Immunology Research
- Pertussis: Microbiology, Disease, Treatment, and Prevention
- (2016) Paul E. Kilgore et al. CLINICAL MICROBIOLOGY REVIEWS
- Epidemiology of pertussis in Denmark, 1995 to 2013
- (2016) Tine Dalby et al. Eurosurveillance
- Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012–2013)
- (2016) Raffaella Palazzo et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Interventions for age-related diseases: Shifting the paradigm
- (2016) Inês Figueira et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Burden of four vaccine preventable diseases in older adults
- (2016) Maartje Kristensen et al. VACCINE
- Routine Immunization of Adults in Canada: Review of the Epidemiology of Vaccine-Preventable Diseases and Current Recommendations for Primary Prevention
- (2016) Michael D Parkins et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Seroprevalence of Antibodies to Pertussis Toxin among Different Age Groups in Thailand after 37 Years of Universal Whole-Cell Pertussis Vaccination
- (2016) Nasamon Wanlapakorn et al. PLoS One
- Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China
- (2016) Hanqing He et al. PLoS One
- The estimated incidence of pertussis in people aged 50 years old in the United States, 2006–2010
- (2015) Cristina Masseria et al. BMC INFECTIOUS DISEASES
- Adult pertussis is unrecognized public health problem in Thailand
- (2015) Nirada Siriyakorn et al. BMC INFECTIOUS DISEASES
- Increasing incidence of pertussis in Brazil: a retrospective study using surveillance data
- (2015) Lucas Melo Guimarães et al. BMC INFECTIOUS DISEASES
- Asymptomatic transmission and the resurgence of Bordetella pertussis
- (2015) Benjamin M. Althouse et al. BMC Medicine
- Pertussis epidemic despite high levels of vaccination coverage with acellular pertussis vaccine
- (2015) Maria-Rosa Sala-Farré et al. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
- Clinical characteristics and pertussis costs in cases reported to epidemiological services and cases detected in household contacts in Catalonia (Spain)
- (2015) P. Plans et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Resurgence of pertussis at the age of vaccination: clinical, epidemiological, and molecular aspects
- (2015) Rosângela S.L.A. Torres et al. Jornal de Pediatria
- Seroprevalence of Pertussis in The Gambia
- (2015) Susana Scott et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pertussis Across the Globe
- (2015) Tina Tan et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Risk factors for pertussis hospitalizations in Australians aged 45 years and over: A population based nested case–control study
- (2015) Surendra Karki et al. VACCINE
- Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological study
- (2015) Piia Jõgi et al. VACCINE
- Community awareness and predictors of uptake of pertussis booster vaccine in South Australian adults
- (2015) Michelle Clarke et al. VACCINE
- Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults
- (2015) Martina Kovac et al. VACCINE
- Pertussis em Portugal – A importância de uma nova estratégia vacinal
- (2015) Susana Gama de Sousa et al. Revista Portuguesa de Pneumologia
- Estimates of the reproduction number for seasonal, pandemic, and zoonotic influenza: a systematic review of the literature
- (2014) Matthew Biggerstaff et al. BMC INFECTIOUS DISEASES
- Incidence and factors predicting whooping cough due to parapertussis diagnosis among patients referred to general practitioners, Poland, 2009–2011
- (2014) R. Tomialoic et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Increase of pertussis incidence in 2010 to 2012 after 12 years of low circulation in Spain
- (2014) V Sizaire et al. Eurosurveillance
- Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity?
- (2014) James D Cherry Expert Review of Vaccines
- Risks for infection in patients with asthma (or other atopic conditions): Is asthma more than a chronic airway disease?
- (2014) Young J. Juhn JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pertussis Resurgence: Perspectives From the Working Group Meeting on Pertussis on the Causes, Possible Paths Forward, and Gaps in Our Knowledge
- (2014) D. L. Burns et al. JOURNAL OF INFECTIOUS DISEASES
- Cost-Effectiveness of Tdap Vaccination of Adults Aged ≥65 Years in the Prevention of Pertussis in the US: A Dynamic Model of Disease Transmission
- (2014) Lisa J. McGarry et al. PLoS One
- Epidemiological evidence for herd immunity induced by acellular pertussis vaccines
- (2014) M. Domenech de Celles et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years
- (2014) Rolf Dominicus et al. VACCINE
- Characteristics of pertussis outbreaks in Catalonia, Spain, 1997 to 2010
- (2014) Inma Crespo et al. Human Vaccines & Immunotherapeutics
- The disease burden of pertussis in adults 50 years old and older in the United States: a retrospective study
- (2013) Catherine Balderston McGuiness et al. BMC INFECTIOUS DISEASES
- Pertussis re-emergence in the post-vaccination era
- (2013) Elena Chiappini et al. BMC INFECTIOUS DISEASES
- Incidence of pertussis in patients of general practitioners in Poland
- (2013) P. STEFANOFF et al. EPIDEMIOLOGY AND INFECTION
- Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark
- (2013) P. F. RØNN et al. EPIDEMIOLOGY AND INFECTION
- Incidence of whooping cough in Spain (1997–2010): an underreported disease
- (2013) María Isabel Fernández-Cano et al. EUROPEAN JOURNAL OF PEDIATRICS
- Pertussis
- (2013) Tara B. Spector et al. MEDICAL CLINICS OF NORTH AMERICA
- Cost-Effectiveness Analysis of Tdap in the Prevention of Pertussis in the Elderly
- (2013) Lisa J. McGarry et al. PLoS One
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model
- (2013) J. M. Warfel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip®) to adults aged ≥60 years: An open-label, randomised trial
- (2013) Ulrich Zimmermann et al. VACCINE
- Seroprevalence of pertussis in China
- (2013) Ying Hua Xu et al. Human Vaccines & Immunotherapeutics
- The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study
- (2012) Qi Zhang et al. BMC INFECTIOUS DISEASES
- Safety of a Tetanus-Diphtheria-Acellular Pertussis Vaccine When Used Off-Label in an Elderly Population
- (2012) H. F. Tseng et al. CLINICAL INFECTIOUS DISEASES
- Pertussis in Older Adults: Prospective Study of Risk Factors and Morbidity
- (2012) B. C. Liu et al. CLINICAL INFECTIOUS DISEASES
- The pertussis epidemic: informing strategies for prevention of severe disease
- (2012) M. F. CLARKE et al. EPIDEMIOLOGY AND INFECTION
- California Pertussis Epidemic, 2010
- (2012) Kathleen Winter et al. JOURNAL OF PEDIATRICS
- Epidemic Pertussis in 2012 — The Resurgence of a Vaccine-Preventable Disease
- (2012) James D. Cherry NEW ENGLAND JOURNAL OF MEDICINE
- Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children
- (2012) Nicola P. Klein et al. NEW ENGLAND JOURNAL OF MEDICINE
- The importance of pertussis in older adults: A growing case for reviewing vaccination strategy in the elderly
- (2012) Iman Ridda et al. VACCINE
- Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials
- (2012) Wayde M. Weston et al. VACCINE
- Pertussis Serodiagnosis in Belgium from 1990 to 2009
- (2011) Muriel Vincent et al. Clinical and Vaccine Immunology
- Rationale for pertussis booster vaccination throughout life in Europe
- (2011) Fred Zepp et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix®) in adults 55 years of age and over: A sub-analysis of four trials
- (2011) Pierre Van Damme et al. VACCINE
- Persistence of antibodies 3 years after booster vaccination of adults with combined acellular pertussis, diphtheria and tetanus toxoids vaccine
- (2011) Wayde Weston et al. VACCINE
- What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories
- (2010) N. Guiso et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations
- (2010) Odile Launay et al. Human vaccines & immunotherapeutics
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussis
- (2010) Sabine C. de Greeff et al. PLoS One
- The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: Experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak
- (2010) Elizabeth A. Talbot et al. VACCINE
- The seroepidemiology of Bordetella pertussis in Israel—Estimate of incidence of infection
- (2010) Pamela Rendi-Wagner et al. VACCINE
- A decennial booster dose of reduced antigen content diphtheria, tetanus, acellular pertussis vaccine (Boostrix™) is immunogenic and well tolerated in adults
- (2010) Robert Booy et al. VACCINE
- The epidemiology of pertussis in Germany: past and present
- (2009) Wiebke Hellenbrand et al. BMC INFECTIOUS DISEASES
- Ageing populations: the challenges ahead
- (2009) Kaare Christensen et al. LANCET
- Economic analysis of pertussis illness in the Dutch population: Implications for current and future vaccination strategies
- (2009) Sabine C. de Greeff et al. VACCINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now